Engaging pharmacogenomics in pain management and opioid selection.

Pharmacogenomics

Department of Medical Ethics, Humanities, & Law, Homer Stryker MD School of Medicine, Western Michigan University, 1000 Oakland Drive, Kalamazoo, MI 49008, USA.

Published: September 2021

Opioid misuse and mismanagement has been a public health crisis for several years. Pharmacogenomics (PGx) has been proposed as another tool to enhance opioid selection and optimization, with recent studies demonstrating successful implementation and outcomes. However, broad engagement with PGx for opioid management is presently limited. The purpose of this article is to highlight a series of barriers to PGx implementation within the specific context of opioid management. Areas of advancement needed for more robust pharmacogenomic engagement with opioids will be discussed, including clinical and economic research needs, education and training needs, policy and public health considerations, as well as legal and ethical issues. Continuing efforts to address these issues may help to further operationalize PGx toward improving opioid use.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656342PMC
http://dx.doi.org/10.2217/pgs-2021-0044DOI Listing

Publication Analysis

Top Keywords

opioid selection
8
public health
8
opioid management
8
opioid
6
engaging pharmacogenomics
4
pharmacogenomics pain
4
pain management
4
management opioid
4
selection opioid
4
opioid misuse
4

Similar Publications

Objectives: To investigate the social support status and associated factors among Vietnamese methadone maintenance patients during the COVID-19 pandemic.

Design: Cross-sectional study.

Setting: Three methadone clinics.

View Article and Find Full Text PDF

Background: Chronic pain is defined as any persistent or recurring pain lasting longer than 3 months that significantly affects a person's quality of life. Millions worldwide are impacted by chronic pain, but its subjective nature makes it difficult to quantify and compare between individuals.

Methods: This retrospective analysis aimed to examine the differences in pain perception and reporting between male and female patients, as well as how their pain was managed.

View Article and Find Full Text PDF

Introduction: Opioid-induced constipation (OIC) affects up to 90% of patients with cancer receiving long-term opioid-related analgesic therapy, resulting in various potential complications, compromised pain management and decreased quality of life. Laxatives stimulate or facilitate bowel evacuation. Traditional laxatives, such as polyethylene glycol and lactulose, are widely used because of their low cost, easy accessibility and tolerability.

View Article and Find Full Text PDF

Background: The substance use crisis continues to progress. Medication for Opioid Use Disorder (MOUD) are prescribed to reduce opioid use and related harms; however, many individuals continue to use substances while on treatment. The objective of this study was to describe the temporal and demographic trends of the agreement between self-reported and urine tested substances.

View Article and Find Full Text PDF

Segmental thoracic spinal anesthesia (STSA) is emerging as a promising alternative for high-risk patients undergoing abdominal surgeries, particularly those who are not optimal candidates for general anesthesia (GA). By selectively targeting the thoracic spinal segments responsible for abdominal innervation, STSA aims to provide precise anesthesia and pain management while minimizing systemic side effects. This case series presents the outcomes of several critical patients who underwent abdominal surgeries under STSA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!